Business briefs: Novo Nordisk, Eli Lilly, Merck
Just as the US has begun to embrace wider HPV vaccination, Japan is doing the opposite. Pharmalot reports that painful side effects have prompted the country's health ministry to reverse its immunization recommendation. Pharmalot says the preventative treatment will still be available, but local health programs will idle active promotion of the vaccine until further studies are done. Merck and GlaxoSmithKline make the HPV vaccines Gardasil and Cervarix, respectively.